Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 8.18
-0.03 (-0.37%)
Aug 26, 2026, 3:00 PM CST
SHA:600664 Market Cap
SHA:600664 has a market cap or net worth of 20.6 billion as of August 26, 2026. Its market cap has increased by 108.67% in one year.
Market Cap
20.60B
Enterprise Value
19.42B
Revenue
15.96B
Ranking
n/a
PE Ratio
68.36
Stock Price
8.18
ChartMarket Cap Chart
Since August 28, 2006, SHA:600664's market cap has increased from 7.45B to 20.60B, an increase of 176.45%. That is a compound annual growth rate of 5.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 20.60B | 137.10% |
| Dec 31, 2025 | 8.69B | -16.46% |
| Dec 31, 2024 | 10.40B | 23.17% |
| Dec 29, 2023 | 8.45B | 11.14% |
| Dec 30, 2022 | 7.60B | -15.00% |
| Dec 31, 2021 | 8.94B | 11.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 22.99B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.17B |
| Tasly Pharmaceutical Group | 22.04B |
| Guangdong Zhongsheng Pharmaceutical | 21.66B |
| Jilin Aodong Pharmaceutical Group | 21.17B |
| Shanghai Haoyuan Chemexpress | 20.90B |
| Hybio Pharmaceutical | 20.74B |
| Betta Pharmaceuticals | 20.69B |